Edge Wealth Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $539K | Hold |
15,000
| – | – | 0.1% | 47 |
|
|
2025
Q1 | $591K | Hold |
15,000
| – | – | 0.12% | 44 |
|
|
2024
Q4 | $452K | Hold |
15,000
| – | – | 0.09% | 48 |
|
|
2024
Q3 | $351K | Hold |
15,000
| – | – | 0.07% | 58 |
|
|
2024
Q2 | $267K | Hold |
15,000
| – | – | 0.06% | 63 |
|
|
2024
Q1 | $228K | Hold |
15,000
| – | – | 0.05% | 67 |
|
|
2023
Q4 | $256K | Hold |
15,000
| – | – | 0.06% | 64 |
|
|
2023
Q3 | $125K | Hold |
15,000
| – | – | 0.03% | 74 |
|
|
2023
Q2 | $373K | Hold |
15,000
| – | – | 0.08% | 56 |
|
|
2023
Q1 | $224K | Hold |
15,000
| – | – | 0.05% | 62 |
|
|
2022
Q4 | $171K | Hold |
15,000
| – | – | 0.04% | 76 |
|
|
2022
Q3 | $92K | Hold |
15,000
| – | – | 0.02% | 77 |
|
|
2022
Q2 | $64K | Hold |
15,000
| – | – | 0.01% | 85 |
|
|
2022
Q1 | $143K | Hold |
15,000
| – | – | 0.03% | 85 |
|
|
2021
Q4 | $285K | Hold |
15,000
| – | – | 0.05% | 83 |
|
|
2021
Q3 | $499K | Hold |
15,000
| – | – | 0.1% | 66 |
|
|
2021
Q2 | $586K | Buy |
15,000
+5,000
| +50% | +$195K | 0.12% | 63 |
|
|
2021
Q1 | $482K | Sell |
10,000
-21,420
| -68% | -$1.03M | 0.1% | 68 |
|
|
2020
Q4 | $1.64M | Sell |
31,420
-2,500
| -7% | -$131K | 0.37% | 49 |
|
|
2020
Q3 | $908K | Buy |
33,920
+1,000
| +3% | +$26.8K | 0.21% | 57 |
|
|
2020
Q2 | $641K | Buy |
32,920
+1,500
| +5% | +$29.2K | 0.12% | 85 |
|
|
2020
Q1 | $311K | Hold |
31,420
| – | – | 0.07% | 112 |
|
|
2019
Q4 | $354K | Hold |
31,420
| – | – | 0.07% | 114 |
|
|
2019
Q3 | $176K | Hold |
31,420
| – | – | 0.04% | 143 |
|
|
2019
Q2 | $270K | Buy |
+31,420
| New | +$270K | 0.06% | 121 |
|